A detailed history of Alpha Centric Advisors LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 12,500 shares of GMED stock, worth $907,875. This represents 0.46% of its overall portfolio holdings.

Number of Shares
12,500
Holding current value
$907,875
% of portfolio
0.46%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$51.15 - $56.52 $639,375 - $706,500
12,500 New
12,500 $670,000
Q3 2023

Nov 13, 2023

BUY
$49.1 - $62.37 $491,000 - $623,700
10,000 New
10,000 $496,000
Q4 2022

Feb 07, 2023

BUY
$58.4 - $75.53 $525,600 - $679,770
9,000 Added 900.0%
10,000 $743,000
Q3 2022

Nov 08, 2022

BUY
$55.32 - $67.54 $55,320 - $67,540
1,000 New
1,000 $60,000
Q1 2021

Mar 09, 2022

SELL
$60.05 - $67.74 $900,750 - $1.02 Million
-15,000 Closed
0 $0
Q2 2020

Mar 11, 2022

BUY
$39.81 - $55.61 $597,150 - $834,150
15,000 New
15,000 $716,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.6B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.